A novel tetrazole–1,8-naphthyridine–amide hybrid: First structurally characterized tetrazolo[1,5-a]-derivative of naphthyridines with a luminescence activity, potency against COVID-19, and anticancer activity
Suman Adhikari, Sourav Nath, Tanushree Sen, Rameez Raza, Onur Şahın, Bagher Eftekhari‐Sis, Ghodrat Mahmoudi, Pranab Borah, Akalesh K. Verma, Damir A. Safin
Topics & Concepts
ChemistryTetrazolePotencyDerivative (finance)AmideCombinatorial chemistryLuminescenceCoronavirus disease 2019 (COVID-19)StereochemistryOrganic chemistryIn vitroBiochemistryMedicineFinancial economicsInfectious disease (medical specialty)PathologyDiseasePhysicsOptoelectronicsEconomicsSynthesis and biological activitySynthesis of Tetrazole DerivativesCancer therapeutics and mechanisms